logo

Latest Financial Updates

Read latest financial news update from our blog

US Secretary of State Anthony Blinken in India: China, Israel, 2+2 Ministerial Dialogue... Top 5 things you need to know
US Secretary of State Anthony Blinken in India: China, Israel, 2+2 Ministerial Dialogue... Top 5 things you need to know

US Secretary of State Antony Blinken is in India to hold talks and bolster bilateral ties...

Admin | Finance | 1 month ago

Alphabet CEO Pichai To Testify In Google Play Trial Tuesday
Alphabet CEO Pichai To Testify In Google Play Trial Tuesday

Epic’s lawyers already have questioned other Google executives to try to show that the com...

Admin | Finance | 1 month ago

Goldman Sachs sees 'clear deficit' of iron ore for the rest of the year
Goldman Sachs sees 'clear deficit' of iron ore for the rest of the year

The iron ore market is looking at a shortfall for the rest of the year due to low inventor...

Admin | Finance | 1 month ago

Calculated Risk
Calculated Risk

Admin | Finance | 1 month ago

Felda chairman says settlers will have to bear losses if sugar price remains low
Felda chairman says settlers will have to bear losses if sugar price remains low

KUALA LUMPUR (Nov 10): The multifold increase in the price of raw sugar since 2020 has cau...

Admin | Finance | 1 month ago

Adani Ports Q2 Results Review - On Track To Achieve Higher End Of FY24 Cargo Volume Guidance: Motilal Oswal
Adani Ports Q2 Results Review - On Track To Achieve Higher End Of FY24 Cargo Volume Guidance: Motilal Oswal

Adani Ports and Special Economic Zone Ltd. reported a revenue growth of 28% YoY to Rs 66.5...

Admin | Finance | 1 month ago

Bata Q2 Results Review - Recovery Expected Ahead Of Festive Season; Maintain 'Accumulate': Dolat Capital
Bata Q2 Results Review - Recovery Expected Ahead Of Festive Season; Maintain 'Accumulate': Dolat Capital

Bata India Ltd.’s Q2 FY24 results came below our estimate. The company’s store network inc...

Admin | Finance | 1 month ago

GSK Pharma Q2 Results Review -Vaccines Witness Pick-Up In Growth: Motilal Oswal
GSK Pharma Q2 Results Review -Vaccines Witness Pick-Up In Growth: Motilal Oswal

GlaxoSmithKline Pharma Ltd. delivered in-line revenue. However, Ebitda/profit after tax wa...

Admin | Finance | 1 month ago

Join Our Newsletter

join our newsletter to receive update from us